Investing.com - Benitec Biopharma ADR reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Benitec Biopharma ADR announced earnings per share of -0.76 on revenue of 1.00K. Analysts polled by Investing.com anticipated EPS of -0.75 on revenue of 35K.
Benitec Biopharma ADR shares are down 2% from the beginning of the year and are trading at 4.95 , down-from-52-week-high.They are under-performing the IBEX 35 which is down 0.23% from the start of the year.
Benitec Biopharma ADR follows other major Healthcare sector earnings this month
Benitec Biopharma ADR's report follows an earnings beat by J&J on January 26, who reported EPS of 1.86 on revenue of 22.48B, compared to forecasts EPS of 1.82 on revenue of 21.66B.
Roche Holding ADR had missed expectations on February 1 with fourth quarter EPS of 1.21 on revenue of 15.88B, compared to forecast for EPS of 1.28 on revenue of 16.45B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar